Literature DB >> 20947808

Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions.

Moon Hee Lee1, Chung Hyun Nahm, Jong Weon Choi.   

Abstract

This study investigated coagulation-related variables, proinflammatory cytokines, and fibrinolytic indices to assess the severity of inflammation in patients with pleural effusions. Tuberculous pleural fluids revealed significantly higher concentrations of tumor necrosis factor-α (TNF-α) and plasminogen activator inhibitor type I (PAI-1) than did malignant and pneumonic pleural fluids. Among the coagulation-related variables, thrombin-antithrombin III complex (TAT) exhibited the largest difference in mean values between pleural fluids and blood samples (125.4 ± 45.1 vs 14.3 ± 20.3 ng/ml, p <0.05). Inflammatory parameters were more closely associated with TAT than tissue type plasminogen activator (tPA), PAI-1, and D-dimers. TAT levels in the severe inflammation group (153.8 ± 45.6 ng/ml) were significantly above those in the mild inflammation group (105.6 ± 38.5 ng/ml, p <0.05); however, no significant differences were observed in PAI-1 and D-dimers levels between the two groups. In conclusion, TNF-α and PAI-1 are important indicators in patients with tuberculous pleural effusions, and measurement of TAT is useful for assessing the severity of inflammation in pleural fluids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947808

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

1.  Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.

Authors:  Galina Florova; Ali O Azghani; Sophia Karandashova; Chris Schaefer; Serge V Yarovoi; Paul J Declerck; Douglas B Cines; Steven Idell; Andrey A Komissarov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

2.  Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.

Authors:  Steven Idell; Galina Florova; Sreerama Shetty; Torry Tucker; Richard Idell; Kathy Koenig; Ali Azghani; Najib M Rahman; Andrey Komissarov
Journal:  Clin Pulm Med       Date:  2017-07

3.  Thrombin Upregulates PAI-1 and Mesothelial-Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis.

Authors:  Cheng-Ying Hsieh; Joen-Rong Sheu; Chih-Hao Yang; Wei-Lin Chen; Jie-Heng Tsai; Chi-Li Chung
Journal:  Int J Mol Sci       Date:  2019-10-13       Impact factor: 5.923

4.  A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.

Authors:  Yulin Zeng; Liwei Wang; Hai Zhou; Yu Qi
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.